NCT02134379 - Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Heart Failure; With Decompensation

Interventions

DEVICE

Medtronic ICDs, CRT-Ds, and CRT-Ps

Any Medtronic implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) device. Device must have capacity to measure thoracic impedance as described in protocol. This includes the majority of FDA-approved Medtronic devices currently in use.

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City